Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Literature DB >> 19755047

NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Paul F Engstrom¹, Juan Pablo Arnoletti, Al B Benson, Yi-Jen Chen, Michael A Choti, Harry S Cooper, Anne Covey, Raza A Dilawari, Dayna S Early, Peter C Enzinger, Marwan G Fakih, James Fleshman, Charles Fuchs, Jean L Grem, Krystyna Kiel, James A Knol, Lucille A Leong, Edward Lin, Mary F Mulcahy, Sujata Rao, David P Ryan, Leonard Saltz, David Shibata, John M Skibber, Constantinos Sofocleous, James Thomas, Alan P Venook, Christopher Willett.

Abstract

Entities: Disease

Mesh：

Year: 2009 PMID： 19755047 DOI： 10.6004/jnccn.2009.0057

Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908

Keyword Cloud
Cited

× No keyword cloud information.

141 in total

1. Recently published indicators allow for comparison of radiation treatment rates relative to evidence-based guidelines for rectal cancer.

Authors: R Rahal; T Forte; G Lockwood; J Klein-Geltink; H Bryant
Journal: Curr Oncol Date: 2012-06 Impact factor: 3.677

Review 2. Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence.

Authors: D Howell; T F Hack; T K Oliver; T Chulak; S Mayo; M Aubin; M Chasen; C C Earle; A J Friedman; E Green; G W Jones; J M Jones; M Parkinson; N Payeur; C M Sabiston; S Sinclair
Journal: J Cancer Surviv Date: 2012-07-10 Impact factor: 4.442

3. Laparoscopic-assisted versus open surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes.

Authors: Mei-Jin Huang; Jing-Lin Liang; Hui Wang; Liang Kang; Yan-Hong Deng; Jian-Ping Wang
Journal: Int J Colorectal Dis Date: 2010-12-21 Impact factor: 2.571

4. MicroRNA hsa-let-7e-5p as a potential prognosis marker for rectal carcinoma with liver metastases.

Authors: Wenfeng Chen; Guosheng Lin; Yizhou Yao; Jishen Chen; Hanli Shui; Qinghai Yang; Xiaoya Wang; Xiaoyuan Weng; Ling Sun; Fei Chen; Sheng Yang; Yufeng Yang; Yongjian Zhou
Journal: Oncol Lett Date: 2018-03-06 Impact factor: 2.967

5. Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.

Authors: Yoichiro Homma; Takashi Hamano; Yasuhiro Akazawa; Yoshiro Otsuki; Shinichi Shimizu; Hiroshi Kobayashi; Shingo Kameoka; Yasuyuki Kobayashi
Journal: Surg Today Date: 2013-08-14 Impact factor: 2.549

6. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.

Authors: Dae Ro Lim; Sung Uk Bae; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Kang Young Lee; Nam Kyu Kim
Journal: Surg Endosc Date: 2016-09-08 Impact factor: 4.584

NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

1. Recently published indicators allow for comparison of radiation treatment rates relative to evidence-based guidelines for rectal cancer.

Review 2. Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence.

3. Laparoscopic-assisted versus open surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes.

4. MicroRNA hsa-let-7e-5p as a potential prognosis marker for rectal carcinoma with liver metastases.

5. Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.

6. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.

7. D-dimer as a potential clinical marker for predicting metastasis and progression in cancer.

8. Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice.

9. Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.

Review 10. KRAS mutation testing in metastatic colorectal cancer.